| 000 | 00866nam a22002657a 4500 | ||
|---|---|---|---|
| 008 | 151019b xxu||||| |||| 00| 0 eng d | ||
| 040 | _cVAD | ||
| 041 | _aEngels | ||
| 100 | _aOlsen, Anna | ||
| 245 | _a Independent evaluation of the 'Implementing Expanded Naloxone Availability in the ACT (I-ENAACT) Program', 2011-2014 : final report. [PDF] | ||
| 260 |
_aMelbourne _bCentre for Research Into Injecting Drug Use _c2015 |
||
| 300 | _a63 p. | ||
| 650 | _adrugs | ||
| 650 | _aheroïne | ||
| 650 | _analoxon | ||
| 650 | _afarmacotherapie | ||
| 650 | _aAustralië | ||
| 650 | _aonderzoeksrapporten | ||
| 650 | _aoverdosis | ||
| 650 | _aevaluatie | ||
| 700 | _aMcDonald, David | ||
| 700 | _aLenton, Simon | ||
| 700 | _aDietze, Paul | ||
| 856 | _uhttp://www.google.com/search?q= Independent-evaluation-of-the-Implementing-Expanded-Naloxone-Availability | ||
| 999 |
_c18116 _d18116 |
||